Why This Citigroup Analyst Believes The Stock Has Reached An ‘Attractive Entry Point’
Shares of Citigroup Inc (NYSE: C) were climbing in early trading on Wednesday.
Trimble’s Growth Catalysts: Analyst Upgrades Stock On Strong Growth Potential Amid Debt Reduction And Buyback
Trimble receives an upgrade from Piper Sandler, foreseeing significant share repurchases and positive catalysts in 2024.
Lowe’s Home Improvement Is A ‘Value Stock Idea’ Despite ‘Muted Rebound’: Analyst
Shares of Lowe's Companies Inc (NYSE: LOW) slipped in early trading on Tuesday.
The pressure on the share of wallet for goods seem to be subsiding, with a resumption in wage growth, according to JPMorgan analyst Christopher Horvers.
Willis Towers Watson To See Short-Term Success Amid Defined Benefit Plan Shifts – Analyst Upgrades Stock
Analyst Zaremski upgraded Willis Towers Watson to Market Perform, predicting continued growth and strong performance in broking and DB segments.
Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise
Shares of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) climbed in early trading on Monday, after several analysts raised their forecasts.
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:
RBC Capital’s Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Outperform, anticipating $21 price target. Data expected in 2H 2024 validates its potential in lupus and rheumatoid arthritis.
Disney Analysts Bullish After Q1 Earnings: ‘The Magic’s Back’
Analysts are upgrading their price targets on Disney stock after the media company reported first-quarter financial results and shared several announcements.
Bullish Klaviyo Analyst Cites 3 Main Catalysts That Bode Well For Stock In 2024
Shares of Klaviyo Inc (NYSE: KVYO) climbed in premarket trading on Monday.
Cigna ‘Top Pick for 2024’: Analysts Change Ratings, Forecasts Following 2024 Guidance
Cigna Group (NYSE: CI) shares were rising in early trading on Monday after the company reported its fourth-quarter results.